HAART Observational Medical Evaluation and Research Cohort (HOMER)
The HAART HOMER cohort was established in 1996 to maintain a prospective record of clinical measurements and medication profiles of a subset of Drug Treatment Program (DTP) participants initiating Highly Active Antiretroviral Therapy (HAART) in British Columbia (BC), Canada. This unique cohort provides a comprehensive data source to investigate mortality, prognostic factors, and treatment response among people living with human immunodeficiency virus (HIV) in BC from the inception of HAART. The cohort is updated annually. The 5,229 individuals enrolled in the HOMER cohort as of 2012 represented approximately 63% of the 8,327 patients who had ever accessed ART through the DTP up until 30 June 2011.
Study design
Cohort - clinical
Number of participants at first data collection
5,229 (participants as of 2012)
Recruitment is ongoing
Age at first data collection
≥ 19 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
1996
Primary Institutions
University of British Columbia (UBC)
Links
No website available
Profile paper DOI
Funders
British Columbia PharmaCare
Ongoing?
Yes
Data types collected
- Secondary data
- None
- None
- Census data
- Healthcare data
Engagement
Keywords
Consortia and dataset groups
